Back

American Association of Immunologists, France Foundation, The

  • Diabetes Mellitus, Type 2
  • Incretins
  • Inflammation
  • Insulin Resistance
  • Obesity

Beyond Glucose: The Immunologic Architecture of Obesity and Type 2 Diabetes An Interactive Monograph

TARGET AUDIENCE This educational activity is intended for AAI membership and Clinicians. PROGRAM OVERVIEW Overview of inflammation as a core mechanism for obesity-associated comorbidities, including T2D. Discussion of the distinct immunologic environments of visceral vs. subcutaneous adipose tissue, how immune dysregulation precedes insulin resistance, how inflammation differs in people compared to animal models, and the practical barriers clinicians face in recognizing elevated inflammatory burden at the point of care. LEARNING OBJECTIVES Upon completion of this activity, learners should be able to: 1. 1. Describe the relationship between chronic inflammation and obesity and T2D 2. 2. Explain the role of adipose tissue in inflammation and immune dysregulation related to T2D and obesity 3. 3. Explain the anti-inflammatory properties of GLP 1 and dual incretin therapies 4. 4. Integrate immunologic and metabolic insights in the management of obesity and T2D

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • includes Article / monograph / reference
  • Credit · Up to 0.75 credits
  • Released
    Aug 31, 2026
  • Last day to claim credit
    Sep 1, 2027 11 months left